Dr. Laurin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5215 Loughboro Road Northwest
Washington, DC 20016Phone+1 202-660-5555Fax+1 202-660-6103
Summary
- Dr. Jacqueline Laurin, based in Washington, DC, is a gastroenterologist with subspecialties in Hepatology & Liver Transplantation. She received her medical degree at the University of Florida College of Medicine, and furthered her training with internships, residencies and fellowships at the University of Maryland and Mayo Clinic College of Medicine and Science. Her employment history includes significant roles at Johns Hopkins Gastroenterology and Hepatology and MedStar Georgetown University Hospital. Additionally, she served as Medical Director of Liver Transplantation at University of Maryland Medical Center. Dr. Laurin has expertise in managing various liver diseases and has published widely in her field. In 2012, she received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 1993 - 1994
- University of MarylandFellowship, Gastroenterology, 1991 - 1993
- University of MarylandResidency, Internal Medicine, 1989 - 1991
- University of FloridaInternship, Internal Medicine, 1988 - 1989
- University of Florida College of MedicineClass of 1988
Certifications & Licensure
- DC State Medical License 1998 - 2026
- MD State Medical License 1989 - 2026
- VA State Medical License 2013 - 2026
- PA State Medical License 2020 - 2022
- MN State Medical License 1993 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC.Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith
Cancer Research Communications. 2024-08-01 - 3 citationsProspective evaluation of patients with non-cirrhotic portal hypertension: A single centre study.Maria Mironova, Harish Gopalakrishna, Gracia Maria Viana Rodriguez, Nehna Abdul Majeed, Asif A Hitawala
Alimentary Pharmacology & Therapeutics. 2024-06-01 - 2 citationsHepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Do...Muhammad Baraa Hammami, Ruhail Kohli, Tinsay Woreta, Mark S. Sulkowski, James P. Hamilton
ACG Case Reports Journal. 2021-05-01
Journal Articles
- Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival Following Liver Transplantation for Hepatitis C VirusJesudian A, Desale S, Julia J, Landry E, Maxwell C, Kallakury B, Laurin J, Shetty K., J Clin Exp Hepatol. 2016 Jun;6(2):109-14., 6/2016
- Use of Adjuvant Sorafenib in Liver Transplant Recipients With High-Risk Hepatocellular CarcinomaShetty K, Dash C, Laurin J., J Transplant. 2014;2014:913634., 2014
- Motion - All Patients With NASH Need to Have a Liver Biopsy: Arguments Against the MotionLaurin J., Can J Gastroenterol. 2002 Oct;16(10):722-6, 10/2002
Professional Memberships
- Member
- American Association for the Study of Liver DiseasesMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: